{"schema":"hottub-news/story/v1","story":"st_7enmdarzhqdoxs42lc6a","title":"Nelkarmi Wins Accelerated FDA Approval for ALK-Positive Lung Cancer That Progressed After Alectinib or Two Earlier Drugs","title_en":"Nelkarmi Wins Accelerated FDA Approval for ALK-Positive Lung Cancer That Progressed After Alectinib or Two Earlier Drugs","outlets":6,"brief":null,"page":"https://hottub.news/stories/fda-approves-nelkarmi-for-previously-treated-alk-lung-cancer-7enmdarzhq","count":6,"items":[{"id":"n_kp5qouc6vxwujy77fh5q","seq":13030660,"kind":"article","title":"FDA Grants Accelerated Approval to Nelkarmi for Pretreated ALK+ NSCLC","url":"https://www.cancertherapyadvisor.com/news/fda-accelerated-approval-nelkarmi-neladalkib-alk-positive-nsclc","published":"2026-11-19T15:00:00Z","seen":"2026-11-19T19:09:45Z","lang":"en","source":{"id":"cancertherapyadvisor.com","name":"cancertherapyadvisor.com","domain":"cancertherapyadvisor.com","outlet":{"wikidata":"Q19321823","name":"Cancer Therapy Advisor","type":"newspaper","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.6499999761581421,"sentiment":"positive","tone":0.05000000074505806,"political":0.07000000029802322},{"id":"n_buuu7bay2xyizwklal6a","seq":12672377,"kind":"article","title":"FDA Approves Nelkarmi, a New Daily Pill for Advanced ALK-Positive Lung Cancer","url":"https://www.webmd.com/drugs/updates/nelkarmi-new-advanced-alk-positive-lung-cancer-daily-pill","published":"2026-11-18T22:45:00Z","seen":"2026-11-18T22:52:29Z","lang":"en","country":"US","source":{"id":"webmd.com","name":"webmd.com","domain":"webmd.com","outlet":{"wikidata":"Q3536160","name":"WebMD","type":"other","country":"US","designations":["corporation"]}},"via":"gdelt-gkg-english","topics":["health","economy"],"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.7099999785423279,"sentiment":"positive","tone":-0.25999999046325684,"political":0.20999999344348907},{"id":"n_svztnownvuyybqfoacia","seq":12644641,"kind":"article","title":"Nelkarmi Wins Accelerated FDA Approval for ALK-Positive Lung Cancer That Progressed After Alectinib or Two Earlier Drugs","url":"https://www.medicaldaily.com/nelkarmi-neladalkib-fda-accelerated-approval-alk-lung-cancer-481392","summary":"The FDA granted accelerated approval to Nelkarmi for advanced ALK-positive non-small cell lung cancer after prior targeted therapies, based on tumor response data from the ALKOVE-1 trial.","published":"2026-11-18T21:33:31Z","seen":"2026-11-18T21:45:21Z","lang":"en","country":"US","source":{"id":"kite-medicaldaily-com-05fda3","name":"medicaldaily.com","domain":"medicaldaily.com","outlet":{"wikidata":"Q69052919","name":"Medical Daily","type":"website","country":"US","designations":["website"]}},"via":"kite-medicaldaily-com-05fda3","topics":["medicine"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q21099132","name":"alectinib","type":"other"}],"mentions":2,"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.5799999833106995,"sentiment":"positive","tone":0.41999998688697815,"political":0.11999999731779099},{"id":"n_k2f6hcn5dldzk3tjiyaa","seq":12706888,"kind":"article","title":"FDA Grants Accelerated Approval to Nelkarmi for Pretreated ALK+ NSCLC","url":"https://www.empr.com/news/fda-accelerated-approval-nelkarmi-neladalkib-alk-positive-nsclc","published":"2026-11-18T19:30:00Z","seen":"2026-11-19T01:27:17Z","lang":"en","source":{"id":"empr.com","name":"empr.com","domain":"empr.com"},"via":"gdelt-gkg-english","topics":["economy","science","health"],"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.6499999761581421,"sentiment":"positive","tone":0.05000000074505806,"political":0.07000000029802322},{"id":"n_5ow5iywcck6eavsiwjba","seq":12409416,"kind":"article","title":"FDA approves Nelkarmi for pretreated ALK+ NSCLC | Company Announcement","url":"https://www.investegate.co.uk/announcement/rns/gsk--gsk/fda-approves-nelkarmi-for-pretreated-alk-nsclc-/9880525","published":"2026-11-18T09:15:00Z","seen":"2026-11-18T09:46:28Z","lang":"en","country":"GB","source":{"id":"investegate.co.uk","name":"investegate.co.uk","domain":"investegate.co.uk"},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Investegate"],"story":"st_7enmdarzhqdoxs42lc6a","category":"economy-business","category_p":0.6200000047683716,"sentiment":"positive","tone":0.1599999964237213,"political":0.05000000074505806},{"id":"n_7enmdarzhqdoxs42lc6a","seq":12250568,"kind":"article","title":"FDA Approves Nelkarmi for Previously Treated ALK+ Lung Cancer","url":"https://www.curetoday.com/view/fda-approves-neladalkib-for-previously-treated-alk-lung-cancer","published":"2026-11-17T18:11:00Z","seen":"2026-11-17T23:36:37Z","lang":"en","source":{"id":"curetoday.com","name":"curetoday.com","domain":"curetoday.com","outlet":{"wikidata":"Q5014714","name":"CURE","type":"magazine","designations":["magazine","website"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_7enmdarzhqdoxs42lc6a","category":"health","category_p":0.6600000262260437,"sentiment":"positive","tone":0.20999999344348907,"political":0.09000000357627869}]}